vancomycin has been researched along with Neutropenia in 247 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (16.19) | 18.7374 |
| 1990's | 104 (42.11) | 18.2507 |
| 2000's | 60 (24.29) | 29.6817 |
| 2010's | 34 (13.77) | 24.3611 |
| 2020's | 9 (3.64) | 2.80 |
| Authors | Studies |
|---|---|
| Alder, JD; Li, T; Mortin, LI; Van Praagh, AD; Zhang, S; Zhang, XX | 1 |
| Clark, RB; Dunwoody, N; Fyfe, C; Grossman, TH; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sun, C; Sutcliffe, JA; Xiao, XY; Zhang, WY; Zhou, J | 1 |
| Akkapeddi, P; Haldar, J; Manjunath, GB; Yarlagadda, V | 1 |
| Allegretta, G; Chang, M; Feltzer, R; Gozun, MMN; Janardhanan, J; Lastochkin, E; Mahasenan, KV; Mobashery, S; Peng, Z; Qian, Y; Schroeder, VA; Tejera, S; Wolter, WR | 1 |
| Liu, A; Sun, C; Xiang, Y; Yuan, Y; Zhao, L | 1 |
| Alegria, W; Bounthavong, M; Deresinski, S; Fox, E; Ha, D; Holubar, M; Meng, L; Mui, E | 1 |
| Akashi, K; Belabbas, T; Egashira, N; Hirota, T; Ieiri, I; Kato, K; Mori, Y; Suetsugu, K; Yamada, T | 1 |
| Fujikawa, T; Hasegawa, D; Kasai, M; Kosaka, Y; Mizuno, S; Uemura, S | 1 |
| Daneman, N; Lam, PW; Leis, JA | 1 |
| Bruns, AHW; de Groot, MCH; Niessen, FA; Raijmakers, RAP; van der Bruggen, T; van Mourik, MSM | 1 |
| Plate, M; van Besien, K | 1 |
| Lintel, H; Saffaf, M | 1 |
| Chan, D; Chang, E; Saedi-Kwon, H; Schwartz, J; Turner, RB; Wilson, DE; Won, R | 1 |
| Chastain, DB; Franco-Paredes, C; Hawkins, WA; Olubajo, B; Wheeler, S | 1 |
| Abdelraouf, K; Kidd, JM; Nicolau, DP | 1 |
| Bury, D; Deenen, MJ; Grouls, RJ; Nijziel, MR; Ter Heine, R; van de Garde, EMW | 1 |
| Harada, S; Kato-Hayashi, H; Kitagawa, J; Matsumoto, T; Niwa, T; Ohata, K; Suzuki, A; Tsurumi, H | 1 |
| Brielmeier, B; Kang, Y; Landon, E; Parsad, S; Pettit, NN; Pisano, J; Vicente, M | 1 |
| Heath, CH; Ingram, PR; Manning, L; Norton, K | 1 |
| Besece, D; Lamp, KC; McConnell, SA; Rolston, KV; White, P; Yoon, M | 1 |
| Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SH; Kwon, JC; Lee, DG; Park, SH; Park, YJ; Yoo, JH | 1 |
| Jenkins, SG; Racanelli, AC; Satlin, MJ; Shore, TB; Soave, R; van Besien, K; Walsh, TJ | 1 |
| Bruggeman, CA; Croes, S; Haeseker, MB; Neef, C; Stolk, LM; Verbon, A | 1 |
| Azzalis, LA; Bacci, MR; Bruniera, FR; Campos Junqueira, VB; da Luz Gonçalves Pedreira, M; Feder, D; Ferreira, FM; Fonseca, FL; Saviolli, LR; Sorgini Peterlini, MA | 1 |
| Arıca, D; Aydın, D; Demirel, N; Gedik, H; Kantürk, A; Şimşek, F; Yıldırmak, T; Yokuş, O | 1 |
| Al Hamal, Z; Chaftari, AM; El Zakhem, A; Gagel, A; Garoge, K; Granwehr, B; Hachem, R; Jiang, Y; Jordan, M; Mulanovich, V; Raad, I; Reitzel, R; Viola, GM; Yousif, A | 1 |
| DeFrates, SR; Hladnik, LM; Nedved, AN; Stockerl-Goldstein, KE | 1 |
| Das, I; Kole, H; Mondal, J; Paul, R; Saha, B; Sarkar, R | 1 |
| Choe, YH; Choi, MH; Jeong, SH; Kim, JH; Lee, SG | 1 |
| Heeney, MM; Hettmer, S | 1 |
| Delgado, G; Mariño, A; Moreno, C; Plaza, D; Salguero, E | 1 |
| Book, L | 1 |
| Sakoulas, G | 1 |
| Rolston, KV | 1 |
| El-Al, AK; El-Mahallawy, HA; El-Wakil, M; Loutfy, SA; Morcos, H | 1 |
| Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L | 1 |
| Gea-Banacloche, JC; Wade, JC | 1 |
| Chang, CM; Chen, PL; Chung, CH; Hung, YP; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Wu, CJ | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Berneman, ZN; Goossens, H; Mebis, J | 1 |
| Agudelo, M; Rodriguez, CA; Salazar, BE; Vesga, O; Zuluaga, AF | 1 |
| Hasuo, K; Hayashi, S; Hayashi, T; Jin, Y; Masuda, M; Rino, Y; Sawazaki, S; Suzuki, H; Tsuchida, K | 1 |
| Watanabe, K | 1 |
| Bournakis, E; Christoulas, D; Dimopoulos, MA; Efstathiou, E; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kastritis, E; Kostis, E; Migkou, M; Papadimitriou, CA; Roussou, M; Terpos, E | 1 |
| Chen, HH; Chou, CH; Hsiao, SH; Lin, WL; Liu Yeh, PY; Wu, TJ | 1 |
| Black, E; Ensom, MH; Lau, TT | 1 |
| Bicking, K; Desai, S; King, EA; McCoy, D; Nyirenda, T | 1 |
| Cheng, AC; Huysmans, M; Peel, T; Spelman, D; Spelman, T | 1 |
| Kimura, Y; Komatsu, T; Sudo, M | 1 |
| Alfandari, S; Berthon, C; Cliquennois, M; Corm, S; Gay, J; Hochart, C; Tricot, S | 1 |
| Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF | 1 |
| Ambrose, PG; Bhavnani, SM; Blais, J; Hegde, SS; Obedencio, G; Okusanya, OO; Shaw, JP; Skinner, R | 1 |
| Duff, JM; Moreb, JS; Muwalla, F | 1 |
| Andes, DR; Craig, WA; Lee, DG; Murakami, Y | 1 |
| Baptista, MI; Da Cunha, CA; Kondo, W; Martins, LT; Rocha, JL | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Asaka, M; Chiba, K; Hashino, S; Imamura, M; Kato, N; Kondo, T; Mori, A; Ota, S; Tanaka, J; Toyoshima, N; Tutumi, Y; Yonezumi, M | 1 |
| Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Bruss, JB; Edge-Padbury, B; Kaplan, SL; Meissner, HC; Morfin, MR; Naberhuis-Stehouwer, S; Townsend, T; Wenman, W | 1 |
| Batiste, B; Bürli, R; Duan, JX; Garcia, M; Gross, M; Hoch, U; Jiang, V; Johnson, KW; Jones, P; Kaizerman, J; Moser, H; Tanaka, R | 1 |
| Adler, H; Frei, R; Widmer, A | 1 |
| Buchheidt, D; Hofheinz, R; Hummel, M | 1 |
| D'Apollo, N; Emilia, G; Longo, G; Luppi, M; Saviola, A; Torelli, G | 1 |
| Glasmacher, A; Wade, JC | 1 |
| Berger, C; Kindli, K; Nadal, D; Niggli, FK | 1 |
| D'Antonio, D; Di Bonaventura, G; Di Giovanni, P; Fiorilli, MP; Fioritoni, G; Francione, A; Manna, A; Parruti, G; Piccolomini, R; Romano, F; Rotolo, S; Savini, V; Schioppa, F; Staniscia, T | 1 |
| Hegde, SS; Judice, JK; Kaniga, K; McCullough, J; Obedencio, G; Pace, J; Reyes, N; Shaw, JP; Skinner, R; Thomas, R; Vanasse, N; Wiens, T | 1 |
| Ahmed, U; Burney, IA; Khan, MA; Shamim, A; Siddiqui, BK; Yosuf, MA; Zakiullah, N | 1 |
| Segarra-Newnham, M; Tagoff, SS | 1 |
| Ansari, M; Deucent, P; Gervaix, A; Ozsahin, H; Taylor, S; Wacker, P | 1 |
| Koster, SA; Mercier, RC; Pai, MP | 1 |
| Hartman, CS; Jaksic, B; Leonard, LB; Martinelli, G; Perez-Oteyza, J; Tack, KJ | 1 |
| Hamadani, M; Kamble, RT; Selby, GB | 1 |
| Agudelo, M; Rodriguez, CA; Salazar, BE; Vesga, O; Zapata, AX; Zuluaga, AF | 1 |
| Camus, C; Tattevin, P | 1 |
| Colson, YL; Marty, FM; Paul, S | 1 |
| Abdullah, WA; Ai, CL; Ariffin, H; Lee, CL | 1 |
| Karabay, O; Koçoğlu, E | 1 |
| Chang, CM; Hsiao, SH; Liao, LH; Lin, CY; Lin, WL; Tsai, JC; Wu, TJ | 1 |
| Ptushkin, VV | 1 |
| Mergenhagen, KA; Pasko, MT | 1 |
| Bolton-Maggs, PH; Clarke, RW; van Saene, HK; Verma, N | 1 |
| Arns, A; Glasmacher, A; Hahn-Ast, C; Marklein, G; Mühling, A; Orlopp, K; Von Lilienfeld-Toal, M | 1 |
| Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J | 1 |
| Amaram, N; Kesarwala, HH; Rahill, WJ | 1 |
| Farber, BF; Moellering, RC | 1 |
| Gale, RP; Ho, WG; Winston, DJ; Young, LS | 1 |
| Zinner, SH | 1 |
| Farwell, AP; Glew, RH; Kendall, LG; Vakil, RD | 1 |
| Armstrong, D; Brown, AE; Friedman, LE; Miller, DR | 1 |
| Klastersky, J; Malarme, M; Meunier-Carpentier, F | 1 |
| King, K | 1 |
| O'Keefe, JP; Strikas, R; Studlo, J; Venezio, FR | 1 |
| Huard, TK; Kauffman, CA; Severance, PJ; Silva, J | 1 |
| West, BC | 2 |
| Bodey, GP; Elting, LS; Rolston, KV | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Abs, L; Bekradda, M; Culine, S; Droz, JP; Farhat, F; Kattan, J | 1 |
| Barker, GJ; Call, SK; Gamis, AS | 1 |
| Giamarellou, H | 1 |
| Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| de Meyer, A; Lauwers, S; Piérard, D | 1 |
| Etienne, J; Fleurette, J; Forey, F; Greenland, T; Lina, B; Troncy, J | 1 |
| Colbert, J; Shinohara, YT | 1 |
| Harousseau, JL; Kergueris, MF; Le Normand, Y; Milpied, N | 1 |
| Jahan, P; Kergueris, MF; Le Normand, Y; Milpied, N | 1 |
| Andremont, A; Boasson, M; Cordonnier, C; Herbrecht, R; Kazmierczak, A; Leverger, G; Marie, JP; Marit, G; Miclea, JM; Schlemmer, B | 1 |
| Barrett, AP; Schifter, M | 1 |
| Bergeron, L; Boucher, FD | 1 |
| Bourcier, JD; Cripps, MC; Evans, WK; Goel, R; Huan, SD; Perrault, DJ; Prosser, IA; Soltys, KM; Tomiak, AT; Yau, JC | 1 |
| Alsar, MJ; Chantal, P; Sacristán, JA; Soto, J | 1 |
| Klastersky, J | 2 |
| Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
| Fischer, L; Lacey, S; Sriskandan, S | 1 |
| Andremont, A; Chiche, D; Guiguet, M; Hayat, M; Lagrange, P; Lapierre, V; Marie, JP; Pico, JL; Richet, H; Tancrede, C | 1 |
| Belghit, M; Brunet, F; Dhainaut, JF; Karmochkine, M; Lanore, JJ; Mira, JP; Monsallier, JF | 1 |
| Bustamante, CI | 1 |
| Henwick, S; Koehler, M; Patrick, CC | 1 |
| Bodey, GP | 1 |
| Dauriac, C; Donio, PY; Grulois, I; Lamy, T; Le Prisé, PY; Michelet, C | 1 |
| Chow, AW; Jewesson, PJ; Kureishi, A; Phillips, GL | 1 |
| Andremont, A; Caillon, J; Flahault, A; Hill, C; Marty, L; Suarez, B | 1 |
| Benne, CA; Bruin, M; de Hoog, GS; Fleer, A; Neeleman, C | 1 |
| Chang, D | 1 |
| Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Autuly, F; Avril, JL; Donnio, PY; Grulois, I; Lamy, T; Le Prisé, PY; Plessis, P | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Drgona, L; Krcmery, V; Kukuckova, E; Lacka, J; Oravcova, E; Trupl, J | 1 |
| Halko, J; Kremery, V; Netriova, D; Studena, M | 1 |
| De Pauw, BE; Deresinski, SC; Dompeling, EC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
| Arsene, O; Colombat, P; Legras, A; Linassier, C; Quentin, R | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Armstrong, D; Boone, N; Brown, A; Chung, M; Delencastre, H; Eagan, J; Henning, KJ; Wollner, N | 1 |
| Concia, E; Cruciani, M; Lazzarini, L; Malena, M; Messori, A; Rampazzo, R; Todeschini, G | 1 |
| Belliveau, P; Kleinjan, J; Lai, KK | 1 |
| Aulagner, G; Barbé, G; Bertrand, Y; Bréant, V; Dürr, F; Nakache, C; Vray, C | 1 |
| Arranz, R; Cámara, R; del Rey, MC; Fernández-Rañada, JM; Figuera, A; Hernández, L; Jiménez, ML; López-Lorenzo, JL; Peñarrubia, MJ; Tomás, JF | 1 |
| Barriga, FJ; Becker, A; Capdeville, V; Martinez, A; Potin, M; Rojo, H; Sapunar, F; Varas, M; Vial, PA | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Demitrovicová, A; Grausová, S; Hal'ko, J; Kral'ovicová, K; Krcméry, V; Krupová, I; Kukucková, E; Netriová, J; Stopková, K; Studená-Mrázová, M; Trupl, J | 1 |
| Anglim, AM; Byers, KE; Farr, BM; Klym, B; Scheld, WM | 1 |
| Esteva-Lorenzo, F; Mazumder, A; Meehan, KR; Verma, UN | 1 |
| Bonmarchand, G; Fruchart, C; Gray, C; Lemeland, JF; Martin, E; Salah, A; Stamatoullas, A; Tilly, H | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Brewrink, J; Cross, AS; McCarter, RJ; Morris, JG; Roghmann, MC | 1 |
| Demitrovicova, A; Grausova, S; Halko, J; Koren, P; Kralovicová, K; Krcmery, V; Krupova, I; Kukuckova, E; Netriova, J; Novotny, J; Spanik, S; Studena-Mrazova, M | 1 |
| Andersen, J; Cassileth, PA; Fernandez, H; Goodman, M; Hanlon, J; Koya, R; Smith, R; Spector, N | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM | 1 |
| Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Ayats, J; Carratalà, J; Domínguez, MA; Fernández de Sevilla, A; Gudiol, F; Liñares, J; Marron, A | 1 |
| Smith, PF; Taylor, CT | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Dranitsaris, G; McGreer, A; Pilla, NJ | 1 |
| Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P | 1 |
| Bruton, J; Champlin, R; Ippoliti, C; Van Besien, K; Warkentin, D | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Berlanga, J; Carratalà, J; Castellsagué, X; Fernández-Sevilla, A; Gudiol, F; Juvé, E; Liñares, J; Niubó, J | 1 |
| Alexander, SW; Pizzo, PA | 1 |
| Egerer, G; Ehrhard, I; Goldschmidt, H; Haas, R; Sonntag, HG; Streich, N | 1 |
| Claeys, G; De Baere, T; Peleman, R; Steyaert, S; Vaneechoutte, M; Verschraegen, G | 1 |
| Feld, R | 1 |
| Adcock, KG; Akins, RL; Farrington, EA | 1 |
| Kikuchi, K; Matsui, Y; Shiseki, M; Totsuka, K | 1 |
| Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I | 1 |
| Bibashi, E; Gompakis, N; Koliouskas, D; Roilides, E; Sidi, V; Tsakiri, A | 1 |
| Bow, L; Nicolau, DP; Nightingale, CH; Onyeji, CO | 1 |
| Dust, WN; Sanche, SE; Shevchuk, YM | 1 |
| Archimbaud, E; Belhabri, A; Bouheddou, N; Fiere, D; Fleurette, J; Michallet, M; Pivot, C; Thiebaut, A; Thomas, X; Troncy, J | 1 |
| Wood, MJ | 1 |
| Bouza, E; Graninger, W; Schaison, G | 1 |
| Menichetti, F | 2 |
| Banevicius, MA; Li, J; Nicolau, DP; Nightingale, CH; Onyeji, CO | 1 |
| Bilíková, E; Kovacicová, G; Krcmery, V; Svetlansky, I | 1 |
| Bergh, K; Kolmannskog, S; Skogen, PG | 1 |
| Fujikawa, T; Kobayashi, I; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Landau, M; Nucci, M; Pulcheri, W; Silveira, F; Spector, N | 1 |
| Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Bouvet, A; Gerbal, R; Marie, JP; Ombandza-Moussa, E; Schlegel, L; Vekhoff, A | 1 |
| Schwartz, MD | 1 |
| Borland, CD; Farrar, WE | 1 |
| Hulse, P; Johnson, A; Oppenheim, BA | 1 |
| Alsar, MJ; Sacristán, JA; Soto, J | 1 |
| Andremont, A; Boutan-Laroze, A; Culine, S; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Bosseray, A; Brion, JP; Hollard, D; Michallet, M; Micoud, M; Nicolini, F; Stahl, JP | 1 |
| Bolger, M; Gilliom, M; Kramer, BS; Malone, JD; Oblon, DJ; Ramphal, R; Rand, KH; Shands, JW; Sherertz, RJ | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Cunningham, R | 1 |
| Cohen, J | 1 |
| Kelsey, SM; Newland, AC; Shaw, E | 1 |
| Chopra, R; Felmingham, D; Robbins, M; Wilson, AP | 1 |
| Riikonen, P | 1 |
| Baglin, TP; Marcus, RE; Warren, RE; Wimperis, JZ | 1 |
| Archimbaud, E; Devaux, Y; Fiere, D; Fleurette, J; Guyotat, D; Maupas, J; Nageotte, A; Ploton, C; Thomas, X | 1 |
| Balistreri, FJ; Cheng, WD; Kenny, MT; Torney, HL | 1 |
| Chow, AW; Cole, CD; Jewesson, PJ; Kureishi, A; Phillips, GL; Reece, DE; Rubinger, M; Smith, JA | 1 |
| Almadrones, L; Curtin, JP; Hakes, TB; Hoskins, WJ; Jones, WB; Lewis, JL; Markman, MM; Reichman, B; Rubin, SC | 1 |
| Eich, G; Neftel, KA | 1 |
| Chomarat, M; Espinouse, D | 1 |
| Attal, M; Bloom, E; Charlet, JP; Huguet, F; Laurent, G; Lemozy, J; Massip, P; Pris, J; Rubie, H; Schlaifer, D | 1 |
| Morris, A; Ward, C | 1 |
| Brunet, F; Dreyfus, F; Giraud, T; Monsallier, JF; Schremmer, B; Vaxelaire, JF; Vedel, G | 1 |
| Brossard, G; Fourche, J; Leng, B; Maugein, J; Pellegrin, JL; Reiffers, J | 1 |
| Brossard, G; Cony-Makhoul, P; Marit, G; Pellegrin, JL; Reiffers, J; Texier-Maugein, J | 1 |
| Cheesbrough, J; Davies, JM; Harding, I; Smith, SR | 1 |
| Bartlett, KH; Chow, AW; Cole, CD; Jewesson, PJ; Kureishi, A | 1 |
| Chiche, D; Leverger, G; Pappo, M; Schaison, G | 1 |
| Shenep, JL | 1 |
| Clark, RA; Hanna, BJ; Kitchen, LW; Pollock, B; Valainis, GT | 1 |
| Anaissie, E; Bodey, GP; Elting, LS; Fainstein, V; Holmes, F; Kantarjian, H; Khardori, N; Murphy, WK; Plager, C; Rolston, K | 1 |
| Moore, PJ; Sacho, H | 1 |
| Baker, DK; Goren, MP; Shenep, JL | 1 |
| Dolezal, JM; Downs, NJ; Hodges, GR; Neihart, RE | 1 |
| Arlet, G; Leblanc, T; Leverger, G; Schaison, G; Siguret, V | 1 |
| Pizzo, PA; Rubin, M | 1 |
| Bourdarias, JP; Leport, C; Rouveix, B; Sirinelli, A; Vilde, JL | 1 |
| Brion, JP; Bru, JP; Corron, B; Fauconnier, J; Michallet, M | 1 |
| Ajchenbaum, F; Baume, D; Chiche, D; Delmer, A; Fitoussi, F; Marie, JP; Pico, JL; Richet, H; Rio, B; Tancrède, C | 1 |
| Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW | 1 |
| Hathorn, JW; Pizzo, PA; Rubin, M | 1 |
| Anaissie, EJ; Bodey, GP; Cabanillas, F; Elting, L; Fainstein, V; Kantarjian, H; McCredie, KB; Rolston, K | 1 |
| Corrado, ML; Hesney, M; Struble, WE | 1 |
| Granowetter, L; Lange, BJ; Wells, H | 1 |
| Boilletot, A; Boutard, P; de Lumley, L; Demeocq, F; Harousseau, JL; Leverger, G; Olive, D; Reinert, P; Taboureau, O; Vannier, JP | 1 |
| Gress, J; Hathorn, JW; Marshall, D; Pizzo, PA; Rubin, M; Steinberg, SM | 1 |
| Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM | 1 |
| Brunet, F; Dhainaut, JF; Dreyfus, F; Huyghebaert, MF; Lanore, JJ; Monsallier, JF; Varet, B | 1 |
| Brooks, GF; Mordenti, J; Ries, C; Tseng, A; Unadkat, N | 1 |
| Chandrasekar, PH; DeLorenzo, W; Levine, DP; Unowsky, J | 1 |
| Crane, LR; Duman, K; Hatfield, SM; Karanes, C; Kiel, RJ | 1 |
| Bothof, T; de Mulder, P; de Pauw, B; de Witte, T; Janssen, J; Verhagen, CS; Williams, K | 1 |
| Gatell, JM; Miró, JM; Rello, J | 1 |
| Heyman, MR; Milsteen, S; Welik, R | 1 |
| Bachand, RL; Chow, AW; Koo, KB | 1 |
| Crossley, KB; Henry, K; Steinberg, I | 1 |
| Fiere, D; Guyotat, D; Plonton, C | 1 |
| Guay, DR; Mackett, RL | 1 |
26 review(s) available for vancomycin and Neutropenia
| Article | Year |
|---|---|
Population pharmacokinetic model and dosing optimization of vancomycin in hematologic malignancies with neutropenia and augmented renal clearance.
Topics: Anti-Bacterial Agents; Hematologic Neoplasms; Humans; Neutropenia; Retrospective Studies; Vancomycin | 2023 |
The use of vancomycin with its therapeutic and adverse effects: a review.
Topics: Anti-Bacterial Agents; Cephalosporins; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neutropenia; Vancomycin | 2015 |
Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Leukemia, Myeloid, Acute; Methicillin-Resistant Staphylococcus aureus; Neutropenia; Staphylococcal Infections; Vancomycin | 2008 |
Improvements in the prevention and management of infectious complications after hematopoietic stem cell transplantation.
Topics: Aspergillosis; Bacterial Infections; Communicable Diseases; Drug Resistance, Bacterial; Fever; Hematopoietic Stem Cell Transplantation; Humans; Immune System; Medical Oncology; Mycoses; Neutropenia; Pneumococcal Infections; Vancomycin | 2009 |
Antibiotic management of febrile neutropenia: current developments and future directions.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Fever; Humans; Neutropenia; Vancomycin | 2010 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.
Topics: Anti-Bacterial Agents; Drug Hypersensitivity; Female; Fever; Humans; Infections; Middle Aged; Neutropenia; Spinal Diseases; Teicoplanin; Vancomycin | 2010 |
Vancomycin-induced neutropenia: is it dose- or duration-related?
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Neutropenia; Prospective Studies; Vancomycin | 2011 |
Probable vancomycin-induced neutropenia.
Topics: Adult; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Osteomyelitis; Vancomycin | 2004 |
Empiric therapy for infections in the febrile, neutropenic, compromised host.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Immunocompromised Host; Lactams; Mycoses; Neutropenia; Quinolones; Sulfamethoxazole; Time Factors; Trimethoprim; Vancomycin; Virus Diseases | 1995 |
Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function.
Topics: Administration, Oral; Colitis; Drug Eruptions; Edema; Erythema; Humans; Infant; Intestinal Absorption; Kidney; Male; Neutropenia; Syndrome; Vancomycin | 1994 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Initial empiric therapy for fever in neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Fever; Humans; Neoplasms; Neutropenia; Risk; Vancomycin | 1993 |
Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Topics: Adolescent; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neoplasms; Neutropenia; Pneumonia; Respiratory Distress Syndrome; Shock, Septic; Skin Diseases; Vancomycin | 1993 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Neoplasms; Neutropenia; Penicillins; Vancomycin | 1996 |
Vancomycin-induced neutropenia associated with fever: similarities between two immune-mediated drug reactions.
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Osteomyelitis; Vancomycin | 1999 |
Current considerations in the management of fever and neutropenia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Female; Fever; Growth Substances; Humans; Male; Neutropenia; Risk Factors; Vancomycin | 1999 |
Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons.
Topics: Anti-Bacterial Agents; Fever; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 1999 |
Comparative safety of teicoplanin and vancomycin.
Topics: Animals; Anti-Bacterial Agents; Drug Eruptions; Drug Hypersensitivity; Erythema; Hearing; Humans; Kidney; Meta-Analysis as Topic; Neutropenia; Pruritus; Syndrome; Teicoplanin; Thrombophlebitis; Vancomycin | 2000 |
Teicoplanin in the treatment of serious infection.
Topics: Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Child; Cross Infection; Drug Administration Schedule; Drug Resistance, Microbial; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Home Care Services; Humans; Intensive Care Units; Joint Diseases; Neutropenia; Staphylococcal Infections; Teicoplanin; Vancomycin | 2000 |
The role of teicoplanin in the treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Fever; Gram-Positive Bacterial Infections; Humans; Neutropenia; Teicoplanin; Vancomycin | 2000 |
[Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].
Topics: Agranulocytosis; Amodiaquine; Animals; Anti-Bacterial Agents; beta-Lactams; Humans; Neutropenia; Vancomycin | 1991 |
Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Fever; Glycopeptides; Humans; Neutropenia; Teicoplanin; Vancomycin | 1990 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
Controversies in the management of febrile neutropenic cancer patients.
Topics: Agranulocytosis; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Fever; Humans; Infection Control; Infections; Lactams; Neoplasms; Neutropenia; Pneumonia; Quinolines; Vancomycin | 1988 |
61 trial(s) available for vancomycin and Neutropenia
| Article | Year |
|---|---|
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Lipoglycopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Pilot Projects; Recurrence; Treatment Outcome; Vancomycin | 2016 |
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Fever; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Length of Stay; Neutropenia; Survival Rate; Transplantation, Autologous; Vancomycin | 2010 |
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Hematologic effects of linezolid in young children.
Topics: Acetamides; Administration, Oral; Age Factors; Anemia; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Hemoglobins; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Neutropenia; Oxazolidinones; Thrombocytopenia; Vancomycin | 2003 |
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin | 2004 |
Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation.
Topics: Adult; Bacteremia; Cost Savings; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 2004 |
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Cefepime monotherapy for treatment of febrile neutropenia in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Malaysia; Male; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 2006 |
Prophylactic granulocyte transfusions during human bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Transfusion; Bone Marrow Transplantation; Child; Colistin; Cytomegalovirus Infections; Evaluation Studies as Topic; Female; Granulocytes; Humans; Infection Control; Male; Middle Aged; Neutropenia; Nystatin; Random Allocation; Transplantation, Homologous; Vancomycin | 1980 |
Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Topics: Administration, Oral; Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Humans; Neutropenia; Nystatin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1983 |
Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Feces; Gentamicins; Humans; Neoplasms; Neutropenia; Pilot Projects; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1981 |
Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Mouth Diseases; Neoplasms; Neutropenia; Ointments; Oral Hygiene; Retrospective Studies; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1995 |
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Child; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Recovery from staphylococcal septicaemia in neutropenic patients without removal of the previously inserted central venous catheter.
Topics: Adult; Catheterization; Catheterization, Central Venous; Humans; Middle Aged; Neutropenia; Sepsis; Staphylococcal Infections; Vancomycin | 1993 |
Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1993 |
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Catheterization, Central Venous; Catheters, Indwelling; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Incidence; Kidney Diseases; Leukemia; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Penicillins; Prevalence; Prospective Studies; Sepsis; Superinfection; Teicoplanin; Tobramycin; Treatment Outcome; Vancomycin | 1993 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin | 1996 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 1996 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
[Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infections; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Thienamycins; Vancomycin | 1996 |
Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Female; Heparin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1997 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Diseases; Neoplasms; Neutropenia; Risk Factors; Slovakia; Vancomycin | 1997 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Piperacillin; Prospective Studies; Time Factors; Vancomycin | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Antineoplastic Agents; Bacteremia; Catheterization, Central Venous; Colony Count, Microbial; Corynebacterium; Corynebacterium Infections; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Female; Heparin; Humans; Leukemia; Male; Middle Aged; Neutropenia; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1999 |
Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2000 |
[Effectiveness of combined vancomycin and pefloxacine in gastrointestinal decontamination for preventing infections after chemotherapy-induced bone marrow aplasia. A randomized double-blind study].
Topics: Adult; Aged; Bacteremia; Bone Marrow Purging; Digestive System; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Pefloxacin; Treatment Outcome; Vancomycin | 2000 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
[Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Neutropenia; Prospective Studies; Ticarcillin; Vancomycin | 1992 |
Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.
Topics: Adolescent; Adult; Aged; Bacteria; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation; Superinfection; Vancomycin | 1992 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Gram-positive infections in neutropenic patients: glycopeptide antibiotic choice.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Neutropenia; Teicoplanin; Vancomycin | 1992 |
Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.
Topics: Adult; Aztreonam; Bacteremia; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Piperacillin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1992 |
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin | 1991 |
Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Infections; Colistin; Double-Blind Method; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Vancomycin | 1991 |
Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Creatinine; Cyclosporine; Double-Blind Method; Drug Interactions; Female; Fever; Glycopeptides; Humans; Kidney Diseases; Male; Middle Aged; Neutropenia; Piperacillin; Teicoplanin; Tobramycin; Vancomycin | 1991 |
Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Marrow Transplantation; Child; Child, Preschool; Female; Fever; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neutropenia; Postoperative Complications; Prospective Studies; Vancomycin | 1991 |
A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Glycopeptides; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1990 |
Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropenic patients.
Topics: Adult; Aged; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Glycopeptides; Humans; Lactams; Male; Middle Aged; Neutropenia; Reproducibility of Results; Teicoplanin; Vancomycin | 1990 |
Beta-lactam regimens for the febrile neutropenic patient.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Ticarcillin; Vancomycin | 1990 |
Vancomycin does not enhance amikacin-induced tubular nephrotoxicity in children.
Topics: Adolescent; Amikacin; Animals; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Fever; Humans; Kidney Diseases; Kidney Tubules; Male; Neutropenia; Proteinuria; Random Allocation; Rats; Ticarcillin; Vancomycin | 1989 |
[Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillins; Prospective Studies; Ticarcillin; Vancomycin | 1988 |
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Neutropenia; Random Allocation; Vancomycin | 1988 |
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin | 1988 |
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Vancomycin | 1988 |
The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Topics: Agranulocytosis; Bacterial Infections; Clinical Trials as Topic; Colistin; Diarrhea; Gastrointestinal Diseases; Humans; Leukemia; Neutropenia; Norfloxacin; Skin Diseases; Sulfamethoxazole; Trimethoprim; Vancomycin | 1988 |
Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Ceftazidime; Cephalothin; Child; Child, Preschool; Drug Therapy, Combination; Fever; Gentamicins; Humans; Infant; Neoplasms; Neutropenia; Random Allocation; Vancomycin | 1988 |
Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bronchopneumonia; Ceftazidime; Cephalothin; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Random Allocation; Sepsis; Vancomycin | 1987 |
A randomized trial of oral vancomycin in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Clinical Trials as Topic; Colistin; Gentamicins; Humans; Leukemia; Middle Aged; Neutropenia; Nystatin; Sepsis; Vancomycin | 1985 |
162 other study(ies) available for vancomycin and Neutropenia
| Article | Year |
|---|---|
Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Daptomycin; Female; Linezolid; Luminescent Measurements; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Peritonitis; Staphylococcus aureus | 2007 |
Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent.
Topics: Animals; Anti-Bacterial Agents; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Neutropenia; Pyrrolidines; Rats; Rats, Sprague-Dawley; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines | 2012 |
Membrane active vancomycin analogues: a strategy to combat bacterial resistance.
Topics: Animals; Bacteremia; Cell Membrane Permeability; Drug Resistance, Bacterial; Enterococcus; Female; HeLa Cells; Hemolysis; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Quaternary Ammonium Compounds; Staphylococcal Infections; Staphylococcus; Structure-Activity Relationship; Triazoles; Vancomycin | 2014 |
Exploration of the Structural Space in 4(3
Topics: Animals; Anti-Bacterial Agents; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Quinazolinones; Staphylococcus aureus; Structure-Activity Relationship | 2020 |
Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records.
Topics: Acyclovir; Aged; Agranulocytosis; Electronic Health Records; Ganciclovir; Humans; Meropenem; Neutropenia; Palonosetron; Thrombocytopenia; Vancomycin; Voriconazole | 2023 |
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia.
Topics: Adult; Bacteremia; Case-Control Studies; Gram-Positive Bacterial Infections; Humans; Neutropenia; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Nosocomial meningitis caused by Staphylococcus haemolyticus in a child with neutropenia in the absence of intracranial devices: a case report.
Topics: Adolescent; Anti-Bacterial Agents; Child; Coagulase; Cross Infection; Hospitals; Humans; Linezolid; Male; Meningitis, Bacterial; Neutropenia; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus haemolyticus; Vancomycin | 2023 |
Antibiotic-Induced Neutropenia in Patients Receiving Outpatient Parenteral Antibiotic Therapy: a Retrospective Cohort Study.
Topics: Ambulatory Care; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Cloxacillin; Humans; Neutropenia; Outpatients; Retrospective Studies; Vancomycin | 2023 |
Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Carbapenems; Controlled Before-After Studies; Female; Humans; Interrupted Time Series Analysis; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Stem Cell Transplantation; Vancomycin | 2020 |
Is less more? Viewpoint on empiric vancomycin therapy of fever and neutropenia after allogeneic stem cell transplantation.
Topics: Adult; Cord Blood Stem Cell Transplantation; Fever; Hematopoietic Stem Cell Transplantation; Humans; Neutropenia; Vancomycin | 2021 |
Neutropenia, Thrombocytopenia, and Eosinophilia: An Unusual Triad in a Patient on Long-Term Vancomycin Therapy.
Topics: Anti-Bacterial Agents; Eosinophilia; Female; Humans; Middle Aged; Neutropenia; Thrombocytopenia; Vancomycin | 2021 |
Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Female; Humans; Incidence; Leukocyte Count; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Evaluating guideline adherence regarding empirical vancomycin use in patients with neutropenic fever.
Topics: Adult; Anti-Bacterial Agents; Empirical Research; Female; Fever; Guideline Adherence; Humans; Logistic Models; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin | 2018 |
Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Linezolid; Lung; Mice, Inbred BALB C; Neutropenia; Oxazolidinones; Pneumonia, Staphylococcal; Protein Synthesis Inhibitors; Tetrazoles; Treatment Outcome; Vancomycin | 2019 |
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Models, Biological; Neutropenia; Vancomycin | 2019 |
Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Japan; Male; Middle Aged; Neutropenia; Retrospective Studies; Teicoplanin; Vancomycin | 2019 |
Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Infection Control; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2013 |
Neutropenia is rare in patients receiving continuous infusions of vancomycin in an Australian Hospital in the Home setting.
Topics: Aged; Australia; Cohort Studies; Female; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin | 2013 |
Daptomycin use in neutropenic patients with documented gram-positive infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vancomycin; Vancomycin Resistance | 2013 |
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adult; Bacteremia; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Neutropenia; Prognosis; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci | 2014 |
Vancomycin dosing in neutropenic patients.
Topics: Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Neutropenia; Vancomycin | 2014 |
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colony Count, Microbial; Cost-Benefit Analysis; Cross Infection; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Mass Screening; Middle Aged; Neutropenia; Retrospective Studies; Turkey; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2014 |
Effect of Linezolid on Hematologic Recovery in Newly Diagnosed Acute Myeloid Leukemia Patients Following Induction Chemotherapy.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Cohort Studies; Daptomycin; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Neutropenia; Neutrophils; Retrospective Studies; Time Factors; Vancomycin | 2016 |
Severe Neutropenia caused by Prolonged Vancomycin Therapy.
Topics: Anti-Bacterial Agents; Humans; Male; Neutropenia; Severity of Illness Index; Time Factors; Vancomycin; Young Adult | 2016 |
Neutropenia is independently associated with sub-therapeutic serum concentration of vancomycin.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Linear Models; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin | 2017 |
Cefepime-induced neutropenia in a teenager.
Topics: Accidents, Traffic; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Female; Humans; Neutropenia; Serratia Infections; Serratia marcescens; Spinal Fractures; Spinal Fusion; Surgical Wound Infection; Vancomycin | 2008 |
Characterising vancomycin's immunotoxic profile using Swiss and CFW mice as an experimental model.
Topics: Animals; Anti-Bacterial Agents; Drugs, Generic; Female; Flow Cytometry; Lymphocyte Activation; Lymphocytosis; Mice; Models, Animal; Neutropenia; Species Specificity; Spleen; Vancomycin | 2009 |
Neutropenic fever following chemotherapy in a patient with lymphoma.
Topics: Aged; Antibiotic Prophylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Catheterization, Central Venous; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infection Control; Lymphoma, Large B-Cell, Diffuse; Neutropenia; Patient Compliance; Patient Education as Topic; Polyethylene Glycols; Prednisone; Recombinant Proteins; Rituximab; Staphylococcal Infections; Vancomycin; Vincristine | 2008 |
Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Soft Tissue Infections; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2008 |
Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Biofilms; Cell Adhesion Molecules; Child; Coagulase; Congo Red; Female; Fever; Genes, Bacterial; Humans; Male; Neoplasms; Neutropenia; Polymerase Chain Reaction; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin | 2009 |
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Topics: Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Eruptions; Female; Fever; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Taiwan; Teicoplanin; Vancomycin | 2009 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Generic vancomycin products fail in vivo despite being pharmaceutical equivalents of the innovator.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drugs, Generic; Humans; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Therapeutic Equivalency; Thigh; Treatment Failure; Vancomycin | 2010 |
[A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas].
Topics: Aged; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fever; Humans; Male; Neutropenia; Sigmoid Neoplasms; Vancomycin | 2010 |
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Dose-Response Relationship, Drug; Enterococcus; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Treatment Failure; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2011 |
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Topics: Adult; Age Factors; Aged; Bacteremia; Bone Marrow Transplantation; Case-Control Studies; Catheterization, Central Venous; Enterococcus; Female; Gastrointestinal Diseases; Hospitals; Humans; Hypoalbuminemia; Male; Meropenem; Metronidazole; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Phenotype; Risk Factors; Thienamycins; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2012 |
[Use of the critical path with the electronic chart system using meropenem, vancomycin, liposome amphotericin B for the febrile neutropenia].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Critical Pathways; Drug Therapy, Combination; Electronic Health Records; Female; Fever; Hematologic Neoplasms; Humans; Liposomes; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Fever; Guideline Adherence; Hospitals, University; Humans; Inappropriate Prescribing; Induction Chemotherapy; Infusions, Intravenous; Kidney Diseases; Leukemia, Myeloid; Neutropenia; Practice Guidelines as Topic; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection model.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drugs, Generic; Female; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Therapeutic Equivalency; Thigh; Tissue Extracts; Vancomycin | 2012 |
Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Colony Count, Microbial; Dimerization; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glycopeptides; Humans; Injections, Subcutaneous; Mice; Microbial Sensitivity Tests; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Thigh; Vancomycin | 2012 |
Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.
Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Leukocyte Count; Neutropenia; Neutrophils; Severity of Illness Index; Treatment Outcome; Vancomycin | 2012 |
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin | 2013 |
Uncommon vancomycin-induced side effects.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Eosinophilia; Erythema; Female; Fever; Hip Prosthesis; Humans; Methicillin Resistance; Middle Aged; Neutropenia; Ofloxacin; Prosthesis-Related Infections; Pruritus; Staphylococcus; Syndrome; Vancomycin | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
The risk of persistent carriage of methicillin-resistant Staphylococcus aureus in hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Drug Resistance, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Male; Methicillin; Neutropenia; Retrospective Studies; Risk; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Pharmacology of novel heteroaromatic polycycle antibacterials.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Infections; Behavior, Animal; Calibration; Cation Transport Proteins; DNA; Dogs; Ether-A-Go-Go Potassium Channels; Female; Heterocyclic Compounds; Linezolid; Male; Mice; Mice, Inbred ICR; Muscle, Skeletal; Mutagens; Neutropenia; Oxazolidinones; Peritonitis; Pneumonia, Pneumococcal; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Vancomycin | 2003 |
Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood; Disease Progression; Drug Resistance, Bacterial; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Male; Microbial Sensitivity Tests; Neutropenia; Risk Assessment; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin; Treatment Failure; Vancomycin | 2003 |
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aza Compounds; Bleomycin; Chlamydophila Infections; Chlamydophila pneumoniae; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Fluoroquinolones; Hodgkin Disease; Humans; Imipenem; Immunocompromised Host; Moxifloxacin; Neutropenia; Pneumonia, Bacterial; Quinolines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Vincristine | 2004 |
Necrotising dermatitis in refractory acute myeloid leukaemia.
Topics: Biopsy; Dermatitis; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Necrosis; Neutropenia; Skin; Staphylococcal Infections; Staphylococcus epidermidis; Thrombocythemia, Essential; Vancomycin | 2003 |
Withholding initial vancomycin in febrile neutropenia despite implanted catheters.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Child; Child, Preschool; Drug Resistance, Bacterial; Fever; Humans; Infant; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Thienamycins; Vancomycin | 2004 |
Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Topics: Acetamides; Aminoglycosides; Animals; Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Endpoint Determination; Female; Gram-Positive Bacterial Infections; Linezolid; Lipoglycopeptides; Methicillin Resistance; Mice; Muscle, Skeletal; Nafcillin; Neutropenia; Oxazolidinones; Protein Binding; Staphylococcal Infections; Subcutaneous Tissue; Vancomycin | 2004 |
Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cloxacillin; Drug Resistance, Bacterial; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Hospitals, University; Humans; Imipenem; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pakistan; Retrospective Studies; Vancomycin | 2004 |
Cutaneous aspergillosis in a child with an acute lymphoblastic leukemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Child, Preschool; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Platelet Transfusion; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 2005 |
Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy.
Topics: Adult; Anti-Bacterial Agents; Female; Home Care Services, Hospital-Based; Hospitals, University; Humans; Incidence; Infusions, Intravenous; Leukocyte Count; Male; Medical Records; Middle Aged; Neutropenia; Neutrophils; New Mexico; Retrospective Studies; Vancomycin | 2006 |
Delayed myeloid engraftment due to vancomycin in allogeneic haematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neutropenia; Transplantation, Homologous; Vancomycin | 2006 |
Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Blood Cell Count; Cyclophosphamide; Disease Models, Animal; Escherichia coli; Female; Immunosuppressive Agents; Leukopenia; Meningoencephalitis; Mice; Mice, Inbred ICR; Models, Animal; Neutropenia; Pneumonia, Bacterial; Random Allocation; Specific Pathogen-Free Organisms; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Vancomycin | 2006 |
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
Topics: Acetamides; Anti-Bacterial Agents; Fever; Humans; Linezolid; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Bone Marrow Transplantation; Cefepime; Cephalosporins; Combined Modality Therapy; Cunninghamella; Daunorubicin; Drug Resistance, Multiple, Fungal; Female; Humans; Imatinib Mesylate; Immunocompromised Host; Lung Diseases, Fungal; Middle Aged; Neutropenia; Piperazines; Pneumonectomy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Transplantation Conditioning; Triazoles; Vancomycin; Vincristine; Voriconazole; Zygomycosis | 2006 |
[Catheter associated Staphylococcus sciuri sepsis in a patient with acute myeloid leukemia].
Topics: Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Drug Resistance, Bacterial; Female; Humans; Leukemia, Myeloid, Acute; Meropenem; Middle Aged; Neutropenia; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Thienamycins; Vancomycin | 2006 |
Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
Topics: Anti-Bacterial Agents; Cross Reactions; Female; Humans; Leukocyte Count; Middle Aged; Neutropenia; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
[Vancomycin resistant enterococci in etiology of neutropenic enterocolitis: prophylaxis, clinical signs and treatment].
Topics: Acetamides; Adolescent; Adult; Anti-Infective Agents; Antineoplastic Agents; Drug Resistance, Bacterial; Enterococcus; Enterocolitis; Feces; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hemorrhage; Humans; Linezolid; Middle Aged; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
Topics: Anti-Bacterial Agents; Daptomycin; Endocarditis; Humans; Male; Methicillin Resistance; Middle Aged; Mitral Valve; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Gut overgrowth of vancomycin-resistant enterococci (VRE) results in linezolid-resistant mutation in a child with severe congenital neutropenia: a case report.
Topics: Acetamides; Anti-Bacterial Agents; Child; Drug Resistance, Multiple, Bacterial; Enterococcus; Humans; Intestines; Linezolid; Mutation; Neutropenia; Oxazolidinones; Protein Synthesis Inhibitors; Stem Cell Transplantation; Streptococcal Infections; Vancomycin; Vancomycin Resistance | 2007 |
An audit of efficacy and toxicity of teicoplanin versus vancomycin in febrile neutropenia: is the different toxicity profile clinically relevant?
Topics: Anti-Bacterial Agents; Creatine; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Infections; Kidney; Male; Middle Aged; Multivariate Analysis; Neutropenia; Teicoplanin; Vancomycin | 2008 |
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria | 2008 |
Vancomycin induced neutropenia.
Topics: Agranulocytosis; Child, Preschool; Female; Humans; Leukocyte Count; Neutropenia; Vancomycin | 1981 |
Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Eruptions; Female; Fever; Humans; Infant; Kidney; Male; Middle Aged; Neutropenia; Phlebitis; Retrospective Studies; Time Factors; Vancomycin | 1983 |
Delayed appearance of vancomycin-induced neutropenia in a patient with chronic renal failure.
Topics: Agranulocytosis; Drug Hypersensitivity; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Neutropenia; Time Factors; Vancomycin | 1984 |
Staphylococcus epidermidis septicemia in children with leukemia and lymphoma.
Topics: Adolescent; Antineoplastic Agents; Catheterization; Child; Child, Preschool; Drainage; Drug Resistance, Microbial; Female; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neutropenia; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1984 |
Prophylactic non-absorbable antibiotics in leukaemic patients.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Feces; Female; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neutropenia; Nystatin; Sepsis; Vancomycin | 1980 |
Vancomycin-induced neutropenia.
Topics: Agranulocytosis; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1982 |
Neutropenia associated with vancomycin therapy.
Topics: Agranulocytosis; Antibodies; Bone Marrow Examination; Endocarditis, Bacterial; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Staphylococcal Infections; Vancomycin | 1982 |
Vancomycin-induced neutropenia.
Topics: Agranulocytosis; Humans; Male; Neutropenia; Staphylococcal Infections; Vancomycin | 1982 |
Vancomycin-induced neutropenia.
Topics: Agranulocytosis; Humans; Male; Middle Aged; Neutropenia; Vancomycin | 1981 |
Bacteremia due to viridans streptococci in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Humans; Neutropenia; Streptococcal Infections; Vancomycin | 1995 |
Viridans streptococci in patients with neutropenia.
Topics: Bacteremia; Digestive System; Environment, Controlled; Humans; Immunocompromised Host; Neutropenia; Streptococcal Infections; Streptococcus; Vancomycin | 1995 |
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Sulbactam; Vancomycin | 1994 |
Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Neutropenia; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus; Vancomycin | 1994 |
Oral source of Staphylococcus epidermidis septicemia in a neutropenic patient.
Topics: Adult; Bacteremia; Catheters, Indwelling; Female; Gingivitis; Humans; Neutropenia; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1994 |
Vancomycin-induced neutropenia during treatment of endocarditis in a pediatric patient.
Topics: Child, Preschool; Endocarditis, Bacterial; Humans; Leukocyte Count; Male; Neutropenia; Neutrophils; Vancomycin | 1994 |
Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patients.
Topics: Adolescent; Adult; Creatinine; Drug Therapy, Computer-Assisted; Female; Gram-Positive Bacterial Infections; Hodgkin Disease; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Vancomycin | 1994 |
Application of USC*PACK clinical programs to vancomycin in neutropenic patients.
Topics: Adolescent; Adult; Bayes Theorem; Creatinine; Drug Therapy, Computer-Assisted; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Neutropenia; Software; Urodynamics; Vancomycin | 1994 |
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Contraindications; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; France; Humans; Immunocompromised Host; Leukocyte Count; Mycoses; Neutropenia; Recurrence; Teicoplanin; Time Factors; Vancomycin | 1994 |
Antibiotic strategy in orofacial/head and neck infections in severe neutropenia.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Protocols; Drug Therapy, Combination; Edema; Face; Female; Humans; Infusions, Intravenous; Lactams; Leukemia; Lymphoma; Male; Metronidazole; Middle Aged; Mouth Diseases; Neck; Neutropenia; Periapical Diseases; Periodontal Diseases; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 1994 |
Duration of intravenous antibiotics for patients with neutropenic fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ceftazidime; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Length of Stay; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Neutrophils; Tobramycin; Vancomycin | 1994 |
Correlation of vancomycin clearance and creatinine clearance: unreliability for predicting initial dosing in neutropenic haematological patients.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Vancomycin | 1993 |
Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia.
Topics: Child, Preschool; Drug Resistance, Microbial; Fatal Outcome; Humans; Lactobacillus; Lactobacillus acidophilus; Male; Middle Aged; Neutropenia; Pneumonia; Vancomycin | 1993 |
Empirical antibiotic therapy for fever in neutropenic patients.
Topics: Anti-Bacterial Agents; Bacteremia; Fever; Humans; Neutropenia; Pneumonia; Superinfection; Vancomycin | 1993 |
Fever and neutropenia during intensive chemotherapy.
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Pseudomonas Infections; Vancomycin | 1993 |
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Cancer Care Facilities; Case-Control Studies; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Length of Stay; Male; Matched-Pair Analysis; Methicillin Resistance; Middle Aged; Neoplasms; Neutropenia; Prognosis; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Survival Rate; Vancomycin | 1993 |
Disseminating infection with Scytalidium dimidiatum in a granulocytopenic child.
Topics: Adolescent; Amikacin; Amphotericin B; Ceftazidime; Drug Therapy, Combination; Humans; Immunocompromised Host; Lymphoma, B-Cell; Male; Mitosporic Fungi; Morocco; Mycoses; Netherlands; Neutropenia; Vancomycin | 1993 |
Influence of malignancy on the pharmacokinetics of vancomycin in infants and children.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Models, Biological; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration.
Topics: Anti-Bacterial Agents; Base Sequence; Drug Resistance, Microbial; Enterococcus; Genotype; Humans; Molecular Sequence Data; Neutropenia; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Vancomycin | 1995 |
Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Monitoring vancomycin serum concentrations in cancer patients undergoing cytotoxic chemotherapy.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Drug Therapy, Combination; Humans; Infusions, Intravenous; Monitoring, Physiologic; Neoplasms; Neutropenia; Prognosis; Vancomycin | 1996 |
Development of listeriosis during vancomycin therapy in a neutropenic patient.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Listeriosis; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.
Topics: Anti-Bacterial Agents; Carrier State; Child; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Oncology Service, Hospital; Risk Factors; Vancomycin | 1996 |
Vancomycin-induced neutropenia treated with granulocyte colony-stimulating factor during home intravenous infusion therapy.
Topics: Adult; General Surgery; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Osteomyelitis; Sepsis; Staphylococcal Infections; Vancomycin | 1996 |
[Clinical, pharmacokinetic and therapeutic study of amikacin with single daily dose and in combination in neutropenic children with fever].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Neutropenia; Penicillins; Piperacillin; Vancomycin | 1996 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Do low vancomycine serum levels predict failures of vancomycine therapy in neutropenic cancer patients?
Topics: Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Retrospective Studies; Treatment Failure; Vancomycin | 1996 |
Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Drug Costs; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Fever; Follow-Up Studies; Gram-Positive Bacterial Infections; Hospital Administration; Hospital Costs; Hospital Departments; Humans; Medical Audit; Neutropenia; Outcome Assessment, Health Care; Pediatrics; Pharmacology, Clinical; Pharmacy Service, Hospital; Policy Making; Practice Patterns, Physicians'; Surgery Department, Hospital; Surgical Procedures, Operative; Vancomycin | 1997 |
Suppression of progenitor cell growth by vancomycin following autologous stem cell transplantation.
Topics: Anti-Bacterial Agents; Bone Marrow Transplantation; Cell Division; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Middle Aged; Multiple Myeloma; Neutropenia; Time Factors; Transplantation, Autologous; Vancomycin | 1997 |
Lactobacillus species as emerging pathogens in neutropenic patients.
Topics: Adult; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Lactobacillus; Male; Middle Aged; Neutropenia; Opportunistic Infections; Penicillins; Vancomycin | 1997 |
Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
Topics: Acute Disease; Bacteremia; Clostridioides difficile; Cohort Studies; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia; Male; Middle Aged; Neutropenia; Risk Factors; Vancomycin | 1997 |
Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Cost-Benefit Analysis; Drug Resistance, Microbial; Female; Fever; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vancomycin | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
[Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1998 |
A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.
Topics: Cancer Care Facilities; Costs and Cost Analysis; Drug Costs; Drug Utilization Review; Hospital Bed Capacity, 100 to 299; Hospitals, Teaching; Humans; Neutropenia; Ontario; Pharmacy Service, Hospital; Practice Guidelines as Topic; Surveys and Questionnaires; Vancomycin | 1994 |
NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network.
Topics: Anti-Bacterial Agents; Fever; Humans; Neutropenia; Vancomycin | 1999 |
Toxicity of single daily dose gentamicin in stem cell transplantation.
Topics: Adult; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Hearing Disorders; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin | 1999 |
Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Drug Administration Schedule; Drug Eruptions; Drug Therapy, Combination; Female; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Teicoplanin; Treatment Outcome; Vancomycin | 1999 |
Septicemia in neutropenic patients infected with Clostridium tertium resistant to cefepime and other expanded-spectrum cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Clostridium; Clostridium Infections; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Sepsis; Vancomycin | 1999 |
Evaluation of empiric vancomycin therapy in children with fever and neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cytarabine; Female; Fever; Humans; Infant; Male; Neutropenia; Retrospective Studies; Vancomycin | 1999 |
Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.
Topics: Animals; Drug Therapy, Combination; Female; Imipenem; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Staphylococcus aureus; Vancomycin | 1999 |
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin | 2000 |
Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Granulocyte Colony-Stimulating Factor; Humans; Mice; Neutropenia; Vancomycin; Vancomycin Resistance | 2000 |
Vancomycin-induced neutropenia resolves after substitution with teicoplanin.
Topics: Adult; Anti-Bacterial Agents; Humans; Male; Neutropenia; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia.
Topics: Animals; Anti-Bacterial Agents; Cytokines; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Granulocyte-Macrophage Colony-Stimulating Factor; Interferon-gamma; Mice; Neutropenia; Recombinant Proteins; Sepsis; Vancomycin | 2001 |
Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
Topics: Bacteremia; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Neutropenia; Predictive Value of Tests; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2001 |
Bactericidal activity in cerebrospinal fluid by treating meningitis caused by Stomatococcus mucilaginosus with rifampicin, cefotaxime and vancomycin in a neutropenic child.
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neutropenia; Rifampin; Vancomycin | 2001 |
Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Translocation; Cyclophosphamide; Drug Therapy, Combination; Enterococcus; Escherichia coli; Gram-Positive Bacterial Infections; Immunosuppressive Agents; Intestines; Kanamycin; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Mice, Nude; Mice, SCID; Neutropenia; Vancomycin; Vancomycin Resistance; Virulence | 2001 |
Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Brazil; Cefepime; Ceftazidime; Cephalosporins; Child; Drug Therapy, Combination; Female; Fever; Hospitals, Teaching; Humans; Male; Middle Aged; Neutropenia; Oxacillin; Practice Guidelines as Topic; Teicoplanin; Treatment Outcome; Vancomycin | 2001 |
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin | 2002 |
[Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Critical Care; Cross Infection; Drug Resistance; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Lactams; Male; Middle Aged; Mouth; Neutropenia; Opportunistic Infections; Pneumococcal Infections; Respiratory Distress Syndrome; Shock, Septic; Species Specificity; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus sanguis; Treatment Outcome; Vancomycin | 2002 |
Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody.
Topics: Anti-Bacterial Agents; Autoantibodies; Blood Cell Count; Fluorescent Antibody Technique; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Recombinant Proteins; Respiratory Tract Infections; Sputum; Vancomycin | 2002 |
Reversible neutropenia from vancomycin.
Topics: Agranulocytosis; Child; Female; Humans; Neutropenia; Remission, Spontaneous; Streptococcal Infections; Vancomycin | 1979 |
Corynebacterium jeikeium meningitis and transverse myelitis in a neutropenic patient.
Topics: Adult; Corynebacterium; Humans; Male; Meningitis, Bacterial; Myelitis; Neutropenia; Vancomycin | 1992 |
[Initial dosage of vancomycin in neutropenic hematologic patients].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Body Weight; Bone Marrow Transplantation; Creatinine; Female; Hematologic Diseases; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Vancomycin | 1992 |
[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Pefloxacin; Piperacillin; Prospective Studies; Renal Insufficiency; Vancomycin | 1992 |
Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
Topics: Animals; Anti-Bacterial Agents; Glycopeptides; Mice; Neutropenia; Reference Values; Staphylococcal Infections; Teicoplanin; Vancomycin | 1992 |
Empiric use of vancomycin in the febrile neutropenic patient.
Topics: Bacteremia; Gram-Positive Bacterial Infections; Humans; Neutropenia; Vancomycin | 1992 |
Enterococcus faecium sensitive to teicoplanin but not vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neutropenia; Teicoplanin; Vancomycin | 1991 |
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
Topics: Adolescent; Adult; Amphotericin B; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Transplantation, Autologous; Vancomycin | 1991 |
Comparative therapeutic efficacy of teicoplanin and vancomycin in normal and in neutropenic mice infected with Staphylococcus haemolyticus.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Female; Glycopeptides; Mice; Neutropenia; Staphylococcal Infections; Teicoplanin; Vancomycin | 1991 |
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cisplatin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Length of Stay; Middle Aged; Neutropenia; Ovarian Neoplasms; Retrospective Studies; Ticarcillin; Vancomycin | 1991 |
Lactobacillus rhamnosus septicemia in patients with prolonged aplasia receiving ceftazidime-vancomycin.
Topics: Ceftazidime; Humans; Lactobacillus; Neutropenia; Sepsis; Vancomycin | 1991 |
High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit.
Topics: Adult; Aged; Coronary Care Units; Female; Humans; Incidence; Leukopenia; Male; Middle Aged; Neutropenia; Operating Rooms; Retrospective Studies; Time Factors; Vancomycin | 1991 |
Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.
Topics: Adult; Drug Resistance, Microbial; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Neutropenia; Remission Induction; Sepsis; Species Specificity; Staphylococcal Infections; Teicoplanin; Vancomycin | 1990 |
In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients.
Topics: Agranulocytosis; Antineoplastic Agents; Coagulase; Drug Resistance, Microbial; Glycopeptides; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia; Staphylococcus; Teicoplanin; Vancomycin | 1990 |
[Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neutropenia; Vancomycin | 1990 |
Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
Topics: Agranulocytosis; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Humans; Infections; Mouth Mucosa; Neoplasms; Neutropenia; Stomatitis; Vancomycin | 1990 |
Vancomycin and neutropenia in AZT-treated AIDS patients with staphylococcal infections.
Topics: Acquired Immunodeficiency Syndrome; Adult; Agranulocytosis; Drug Synergism; Humans; Neutropenia; Staphylococcal Infections; Vancomycin; Zidovudine | 1990 |
Vancomycin-induced neutropenia.
Topics: Agranulocytosis; Humans; Neutropenia; Vancomycin | 1989 |
Mild nephrotoxicity associated with vancomycin use.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Creatinine; Drug Interactions; Drug Therapy, Combination; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Neutropenia; Phlebitis; Risk Factors; Vancomycin | 1989 |
[Frequency and severity of systemic infections caused by Streptococcus mitis and sanguis II in neutropenic children].
Topics: Adolescent; Agranulocytosis; Child; Child, Preschool; Female; Humans; Male; Microbial Sensitivity Tests; Neutropenia; Penicillins; Sepsis; Streptococcal Infections; Streptococcus sanguis; Vancomycin | 1989 |
Antibiotics for the treatment of febrile children with neutropenia and cancer.
Topics: Agranulocytosis; Bacterial Infections; Child; Drug Therapy, Combination; Fever; Humans; Neoplasms; Neutropenia; Vancomycin | 1989 |
[Neutropenia induced by vancomycin. An immuno-allergic mechanism].
Topics: Agranulocytosis; Female; Humans; Middle Aged; Neutropenia; Vancomycin | 1986 |
[Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
Topics: Adolescent; Agranulocytosis; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Netilmicin; Neutropenia; Vancomycin | 1987 |
Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Fever; Gram-Positive Bacteria; Humans; Neoplasms; Neutropenia; Random Allocation; Retrospective Studies; Sepsis; Staphylococcus; Streptococcus; Vancomycin | 1988 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Leukemia; Middle Aged; Neutropenia; Vancomycin | 1988 |
Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Humans; Neutropenia; Tobramycin; Vancomycin | 1988 |
Vancomycin-induced neutropenia complicating bone marrow recovery in a patient with leukemia. Case report and review of the literature.
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Humans; Infusions, Parenteral; Leukemia, Myeloid; Male; Mezlocillin; Neutropenia; Tobramycin; Vancomycin | 1986 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; Methicillin; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Miconazole-induced alteration in tobramycin pharmacokinetics.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Cholesterol; Drug Interactions; Female; Humans; Kinetics; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Time Factors; Tobramycin; Triglycerides; Vancomycin | 1986 |
[Leukopenia associated with the administration of vancomycin].
Topics: Agranulocytosis; Humans; Neutropenia; Vancomycin | 1987 |
Prolonged vancomycin-associated neutropenia in a chronic hemodialysis patient.
Topics: Adult; Agranulocytosis; Arteriovenous Shunt, Surgical; Bacterial Infections; Humans; Male; Neutropenia; Renal Dialysis; Vancomycin | 1987 |
Vancomycin-induced neutropenia.
Topics: Agranulocytosis; Creatinine; Female; Humans; Leukocyte Count; Middle Aged; Neutropenia; Vancomycin | 1986 |
Vancomycin-induced neutropenia during treatment of osteomyelitis in an outpatient.
Topics: Agranulocytosis; Ambulatory Care; Humans; Leukocyte Count; Male; Middle Aged; Neutropenia; Osteomyelitis; Vancomycin | 1986 |
Vancomycin-induced neutropenia.
Topics: Aged; Agranulocytosis; Female; Humans; Leukocyte Count; Neutropenia; Vancomycin | 1985 |